331 related articles for article (PubMed ID: 26213462)
1. Bacteriophage-based therapy in cystic fibrosis-associated Pseudomonas aeruginosa infections: rationale and current status.
Hraiech S; Brégeon F; Rolain JM
Drug Des Devel Ther; 2015; 9():3653-63. PubMed ID: 26213462
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of bacteriophages in the sputum of cystic fibrosis patients.
Saussereau E; Vachier I; Chiron R; Godbert B; Sermet I; Dufour N; Pirnay JP; De Vos D; Carrié F; Molinari N; Debarbieux L
Clin Microbiol Infect; 2014 Dec; 20(12):O983-90. PubMed ID: 24920209
[TBL] [Abstract][Full Text] [Related]
3. Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells.
Alemayehu D; Casey PG; McAuliffe O; Guinane CM; Martin JG; Shanahan F; Coffey A; Ross RP; Hill C
mBio; 2012; 3(2):e00029-12. PubMed ID: 22396480
[TBL] [Abstract][Full Text] [Related]
4. Design of a Broad-Range Bacteriophage Cocktail That Reduces Pseudomonas aeruginosa Biofilms and Treats Acute Infections in Two Animal Models.
Forti F; Roach DR; Cafora M; Pasini ME; Horner DS; Fiscarelli EV; Rossitto M; Cariani L; Briani F; Debarbieux L; Ghisotti D
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29555626
[TBL] [Abstract][Full Text] [Related]
5. Bacteriophage Delivery by Nebulization and Efficacy Against Phenotypically Diverse Pseudomonas aeruginosa from Cystic Fibrosis Patients.
Sahota JS; Smith CM; Radhakrishnan P; Winstanley C; Goderdzishvili M; Chanishvili N; Kadioglu A; O'Callaghan C; Clokie MR
J Aerosol Med Pulm Drug Deliv; 2015 Oct; 28(5):353-60. PubMed ID: 25714328
[TBL] [Abstract][Full Text] [Related]
6. A systematic review on the use of bacteriophage in treating Staphylococcus aureus and Pseudomonas aeruginosa infections in cystic fibrosis.
Singh J; Yeoh E; Fitzgerald DA; Selvadurai H
Paediatr Respir Rev; 2023 Dec; 48():3-9. PubMed ID: 37598024
[TBL] [Abstract][Full Text] [Related]
7. Bacteriophages in the experimental treatment of Pseudomonas aeruginosa infections in mice.
Saussereau E; Debarbieux L
Adv Virus Res; 2012; 83():123-41. PubMed ID: 22748810
[TBL] [Abstract][Full Text] [Related]
8. Rapid and quantitative automated measurement of bacteriophage activity against cystic fibrosis isolates of Pseudomonas aeruginosa.
Cooper CJ; Denyer SP; Maillard JY
J Appl Microbiol; 2011 Mar; 110(3):631-40. PubMed ID: 21205097
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary bacteriophage therapy on Pseudomonas aeruginosa cystic fibrosis strains: first steps towards treatment and prevention.
Morello E; Saussereau E; Maura D; Huerre M; Touqui L; Debarbieux L
PLoS One; 2011 Feb; 6(2):e16963. PubMed ID: 21347240
[TBL] [Abstract][Full Text] [Related]
10. Current knowledge in the use of bacteriophages to combat infections caused by Pseudomonas aeruginosa in cystic fibrosis.
Martínez-Gallardo MJ; Villicaña C; Yocupicio-Monroy M; Alcaraz-Estrada SL; León-Félix J
Folia Microbiol (Praha); 2023 Feb; 68(1):1-16. PubMed ID: 35931928
[TBL] [Abstract][Full Text] [Related]
11. Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos.
Cafora M; Forti F; Briani F; Ghisotti D; Pistocchi A
J Vis Exp; 2020 May; (159):. PubMed ID: 32478753
[TBL] [Abstract][Full Text] [Related]
12. Vaccination against respiratory Pseudomonas aeruginosa infection.
Grimwood K; Kyd JM; Owen SJ; Massa HM; Cripps AW
Hum Vaccin Immunother; 2015; 11(1):14-20. PubMed ID: 25483510
[TBL] [Abstract][Full Text] [Related]
13. Phage therapy is highly effective against chronic lung infections with
Waters EM; Neill DR; Kaman B; Sahota JS; Clokie MRJ; Winstanley C; Kadioglu A
Thorax; 2017 Jul; 72(7):666-667. PubMed ID: 28265031
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and dynamics of Lactobacillus sp. in the lower respiratory tract of patients with cystic fibrosis.
Fangous MS; Lazzouni I; Alexandre Y; Gouriou S; Boisramé S; Vallet S; Le Bihan J; Ramel S; Héry-Arnaud G; Le Berre R
Res Microbiol; 2018; 169(4-5):222-226. PubMed ID: 29800681
[TBL] [Abstract][Full Text] [Related]
15. Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients.
Taccetti G; Campana S; Festini F; Mascherini M; Döring G
Eur Respir J; 2005 Sep; 26(3):458-61. PubMed ID: 16135728
[TBL] [Abstract][Full Text] [Related]
16. The potential of phage therapy in cystic fibrosis: Essential human-bacterial-phage interactions and delivery considerations for use in Pseudomonas aeruginosa-infected airways.
Trend S; Fonceca AM; Ditcham WG; Kicic A; Cf A
J Cyst Fibros; 2017 Nov; 16(6):663-670. PubMed ID: 28720345
[TBL] [Abstract][Full Text] [Related]
17. Use of bacteriophages in the treatment of Pseudomonas aeruginosa infections.
Soothill J
Expert Rev Anti Infect Ther; 2013 Sep; 11(9):909-15. PubMed ID: 24053272
[TBL] [Abstract][Full Text] [Related]
18. Phage therapy against Pseudomonas aeruginosa infections in a cystic fibrosis zebrafish model.
Cafora M; Deflorian G; Forti F; Ferrari L; Binelli G; Briani F; Ghisotti D; Pistocchi A
Sci Rep; 2019 Feb; 9(1):1527. PubMed ID: 30728389
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of the Novel Antibiotic POL7001 in Preclinical Models of Pseudomonas aeruginosa Pneumonia.
Cigana C; Bernardini F; Facchini M; Alcalá-Franco B; Riva C; De Fino I; Rossi A; Ranucci S; Misson P; Chevalier E; Brodmann M; Schmitt M; Wach A; Dale GE; Obrecht D; Bragonzi A
Antimicrob Agents Chemother; 2016 Aug; 60(8):4991-5000. PubMed ID: 27297477
[TBL] [Abstract][Full Text] [Related]
20. Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence.
Bragonzi A; Paroni M; Nonis A; Cramer N; Montanari S; Rejman J; Di Serio C; Döring G; Tümmler B
Am J Respir Crit Care Med; 2009 Jul; 180(2):138-45. PubMed ID: 19423715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
